These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12874758)

  • 21. [Expression of Her2/neu in locally advanced bladder cancer: implication for a molecular targeted therapy].
    Wülfing C; von Struensee D; Bierer S; Bögemann M; Hertle L; Eltze E
    Aktuelle Urol; 2005 Sep; 36(5):423-9. PubMed ID: 16163605
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HER2/neu gene amplification and protein overexpression in G3 pT2 transitional cell carcinoma of the bladder: a role for anti-HER2 therapy?
    Latif Z; Watters AD; Dunn I; Grigor K; Underwood MA; Bartlett JM
    Eur J Cancer; 2004 Jan; 40(1):56-63. PubMed ID: 14687790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HER-2/neu overexpression and amplification in uterine serous papillary carcinoma: comparative analysis of immunohistochemistry, real-time reverse transcription-polymerase chain reaction, and fluorescence in situ hybridization.
    Odicino FE; Bignotti E; Rossi E; Pasinetti B; Tassi RA; Donzelli C; Falchetti M; Fontana P; Grigolato PG; Pecorelli S
    Int J Gynecol Cancer; 2008; 18(1):14-21. PubMed ID: 17451461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Quantitative PCR--new diagnostic tool for quantifying specific mRNA and DNA molecules: HER2/neu DNA quantification with LightCycler real-time PCR in comparison with immunohistochemistry and fluorescence in situ hybridization.
    Schlemmer BO; Sorensen BS; Overgaard J; Olsen KE; Gjerdrum LM; Nexo E
    Scand J Clin Lab Invest; 2004; 64(5):511-22. PubMed ID: 15276916
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Absence of SYT-SSX fusion products in soft tissue tumors other than synovial sarcoma.
    van de Rijn M; Barr FG; Collins MH; Xiong QB; Fisher C
    Am J Clin Pathol; 1999 Jul; 112(1):43-9. PubMed ID: 10396284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Detection of chromosomal aberration in paraffin-embedded synovial sarcoma tissues by fluorescence in-situ hybridization].
    Cheng YF; Wang J; Zhou XY; Zhou XK; Lu YM; Shi DR
    Zhonghua Bing Li Xue Za Zhi; 2007 Sep; 36(9):577-81. PubMed ID: 18070443
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Overexpression of the HER-2 oncogene does not play a role in high-grade osteosarcomas.
    Anninga JK; van de Vijver MJ; Cleton-Jansen AM; Kristel PM; Taminiau AH; Nooij M; Egeler RM; Hogendoorn PC
    Eur J Cancer; 2004 May; 40(7):963-70. PubMed ID: 15093570
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of polysomy 17 in transitional cell carcinoma of the bladder: immunohistochemical study of HER2/neu expression and fish analysis of c-erbB-2 gene and chromosome 17.
    Simonetti S; Russo R; Ciancia G; Altieri V; De Rosa G; Insabato L
    Int J Surg Pathol; 2009 Jun; 17(3):198-205. PubMed ID: 19443884
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Molecular detection of SS18-SSX fusion gene transcripts by cRNA in situ hybridization in synovial sarcoma using formalin-fixed, paraffin-embedded tumor tissue specimens.
    Kanemitsu S; Hisaoka M; Shimajiri S; Matsuyama A; Hashimoto H
    Diagn Mol Pathol; 2007 Mar; 16(1):9-17. PubMed ID: 17471153
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
    Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
    Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical significance of Caveolin-1, Caveolin-2 and HER2/neu mRNA expression in human breast cancer.
    Sagara Y; Mimori K; Yoshinaga K; Tanaka F; Nishida K; Ohno S; Inoue H; Mori M
    Br J Cancer; 2004 Aug; 91(5):959-65. PubMed ID: 15305200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Topoisomerase IIalpha and HER2/neu gene alterations and their correlation in pancreatic ductal adenocarcinomas].
    Liang ZY; Wang WZ; Gao J; Wu SF; Zeng X; Liu TH
    Zhonghua Bing Li Xue Za Zhi; 2007 Feb; 36(2):102-6. PubMed ID: 17493384
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prospective evaluation of TLE1 as a diagnostic immunohistochemical marker in synovial sarcoma.
    Jagdis A; Rubin BP; Tubbs RR; Pacheco M; Nielsen TO
    Am J Surg Pathol; 2009 Dec; 33(12):1743-51. PubMed ID: 19809272
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Stem cell transcription factor SOX2 in synovial sarcoma and other soft tissue tumors.
    Zayed H; Petersen I
    Pathol Res Pract; 2018 Jul; 214(7):1000-1007. PubMed ID: 29773426
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Determination of HER2/neu status in uterine serous papillary carcinoma: Comparative analysis of immunohistochemistry and fluorescence in situ hybridization.
    Santin AD; Bellone S; Van Stedum S; Bushen W; De Las Casas LE; Korourian S; Tian E; Roman JJ; Burnett A; Pecorelli S
    Gynecol Oncol; 2005 Jul; 98(1):24-30. PubMed ID: 15894362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prognostic value of HER2 status in bladder transitional cell carcinoma revealed by both IHC and BDISH techniques.
    Nedjadi T; Al-Maghrabi J; Assidi M; Dallol A; Al-Kattabi H; Chaudhary A; Al-Sayyad A; Al-Ammari A; Abuzenadah A; Buhmeida A; Al-Qahtani M
    BMC Cancer; 2016 Aug; 16():653. PubMed ID: 27539085
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Her2, EGFR and TOPIIA gene amplification and protein expression in synovial sarcoma before and after combined treatment.
    Ptaszyński K; Szumera-Ciećkiewicz A; Zakrzewska K; Tuziak T; Mrozkowiak A; Rutkowski P
    Pol J Pathol; 2009; 60(1):10-8. PubMed ID: 19670699
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of SYT-SSX fusion transcripts in archival synovial sarcomas by real-time reverse transcriptase-polymerase chain reaction.
    Bijwaard KE; Fetsch JF; Przygodzki R; Taubenberger JK; Lichy JH
    J Mol Diagn; 2002 Feb; 4(1):59-64. PubMed ID: 11826189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined detection of Her2/neu gene amplification and protein overexpression in effusions from patients with breast and ovarian cancer.
    Schlüter B; Gerhards R; Strumberg D; Voigtmann R
    J Cancer Res Clin Oncol; 2010 Sep; 136(9):1389-400. PubMed ID: 20217132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Roles of immunohistochemistry and detection of SYT-SSX fusion gene in diagnosis of synovial sarcoma].
    Sun Y; Sun BC; Zhao XL; Wang J; Chen J; Li XQ; Feng YM; Fang ZW; Hao XS
    Zhonghua Bing Li Xue Za Zhi; 2007 Jul; 36(7):480-4. PubMed ID: 17845763
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.